SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Choi HK, Mount DB, Reginato AM, American College of Physicians, American Physiological Society. Pathogenesis of gout. Ann Intern Med 2005; 143: 499516.
  • 2
    Hall AP, Barry PE, Dawber TR, McNamara PM. Epidemiology of gout and hyperuricemia: a long-term population study. Am J Med 1967; 42: 2737.
  • 3
    Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study. Am J Med 1987; 82: 4216.
  • 4
    Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum 2004; 51: 3215.
  • 5
    Singer JZ, Wallace SL. The allopurinol hypersensitivity syndrome: unnecessary morbidity and mortality. Arthritis Rheum 1986; 29: 827.
  • 6
    Hertz P, Yager H, Richardson JA. Probenecid-induced nephrotic syndrome. Arch Pathol 1972; 94: 2413.
  • 7
    Conaghan PG, Day RO. Risks and benefits of drugs used in the management and prevention of gout. Drug Saf 1994; 11: 2528.
  • 8
    Gelber AC. A little citrus might go a long way! J Rheumatol 2008; 35: 16924.
  • 9
    Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004; 350: 1093103.
  • 10
    Huang HY, Appel LJ, Choi MJ, Gelber AC, Charleston J, Norkus EP, et al. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum 2005; 52: 18437.
  • 11
    Feigelson P. The inhibition of xanthine oxidase in vitro by trace amounts of I-ascorbic acid. J Biol Chem 1952; 197: 84350.
  • 12
    Barja G, Lopez-Torres M, Perez-Campo R, Rojas C, Cadenas S, Prat J, et al. Dietary vitamin C decreases endogenous protein oxidative damage, malondialdehyde, and lipid peroxidation and maintains fatty acid unsaturation in the guinea pig liver. Free Radic Biol Med 1994; 17: 10515.
  • 13
    Rojas C, Cadenas S, Perez-Campo R, Lopez-Torres M, Barja G. Effect of vitamin C on antioxidants, lipid peroxidation, and GSH system in the normal guinea pig heart. J Nutr Sci Vitaminol (Tokyo) 1994; 40: 41120.
  • 14
    Stein HB, Hasan A, Fox IH. Ascorbic acid-induced uricosuria: a consequency of megavitamin therapy. Ann Intern Med 1976; 84: 3858.
  • 15
    Van Steirteghem AC, Robertson EA, Young DS. Influence of large doses of ascorbic acid on laboratory test results. Clin Chem 1978; 24: 547.
  • 16
    Berger L, Gerson CD, Yu TF. The effect of ascorbic acid on uric acid excretion with a commentary on the renal handling of ascorbic acid. Am J Med 1977; 62: 716.
  • 17
    Sutton JL, Basu TK, Dickerson JW. Effect of large doses of ascorbic acid in man on some nitrogenous components of urine. Hum Nutr Appl Nutr 1983; 37: 13640.
  • 18
    Lonnrot K, Metsa-Ketela T, Molnar G, Ahonen JP, Latvala M, Peltola J, et al. The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity. Free Radic Biol Med 1996; 21: 2117.
  • 19
    Ersoy A, Dilek K, Yavuz M, Gullulu M, Yurtkuran M. The effect of vitamin C on laboratory tests in haemodialysis patients: is there a relationship between the administered vitamin C dose and serum uric acid levels? [letter]. Nephrol Dial Transplant 1999; 14: 252930.
  • 20
    Tauler P, Aguilo A, Gimeno I, Fuentespina E, Tur JA, Pons A. Influence of vitamin C diet supplementation on endogenous antioxidant defences during exhaustive exercise. Pflugers Arch 2003; 446: 65864.
  • 21
    Sinha R, Block G, Taylor PR. Determinants of plasma ascorbic acid in a healthy male population. Cancer Epidemiol Biomarkers Prev 1992; 1: 297302.
  • 22
    Gao X, Curhan G, Forman JP, Ascherio A, Choi HK. Vitamin C intake and serum uric acid concentration in men. J Rheumatol 2008; 35: 18538.
  • 23
    Choi HK, Gao X, Curhan G. Vitamin C intake and the risk of gout in men: a prospective study. Arch Intern Med 2009; 169: 5027.
  • 24
    Lagowska-Lenard M, Stelmasiak Z, Bartosik-Psujek H. Influence of vitamin C on markers of oxidative stress in the earliest period of ischemic stroke. Pharmacol Rep 2010; 62: 7516.
  • 25
    Naziroglu M, Simsek M. Effects of hormone replacement therapy with vitamin C and E supplementation on plasma thyroid hormone levels in postmenopausal women with type 2 diabetes. Biomed Pharmacother 2009; 63: 71722.
  • 26
    Teixeira VH, Valente HF, Casal SI, Marques AF, Moreira PA. Antioxidants do not prevent postexercise peroxidation and may delay muscle recovery. Med Sci Sports Exerc 2009; 41: 175260.
  • 27
    Polidori MC, Pratico D, Ingegni T, Mariani E, Spazzafumo L, Del Sindaco P, et al. Effects of vitamin C and aspirin in ischemic stroke-related lipid peroxidation: results of the AVASAS (Aspirin Versus Ascorbic Acid Plus Aspirin in Stroke) Study. Biofactors 2005; 24: 26574.
  • 28
    Van Hoydonck PG, Schouten EG, Manuel-Y-Keenoy B, van Campenhout A, Hoppenbrouwers KP, Temme EH. Does vitamin C supplementation influence the levels of circulating oxidized LDL, sICAM-1, sVCAM-1 and vWF-antigen in healthy male smokers? Eur J Clin Nutr 2004; 58: 158793.
  • 29
    Vrca VB, Skreb F, Cepelak I, Romic Z, Mayer L. Supplementation with antioxidants in the treatment of Graves' disease: the effect on glutathione peroxidase activity and concentration of selenium. Clin Chim Acta 2004; 341: 5563.
  • 30
    Yanai H, Morimoto M. Effect of ascorbate on serum lipids and urate metabolism during exhaustive training. Clin Sci (Lond) 2004; 106: 1079.
  • 31
    Nieman DC, Henson DA, McAnulty SR, McAnulty L, Swick NS, Utter AC, et al. Influence of vitamin C supplementation on oxidative and immune changes after an ultramarathon. J Appl Physiol 2002; 92: 19707.
  • 32
    Martinez-Abundis E, Pascoe-Gonzalez S, Gonzalez-Ortiz M, Mora-Martinez JM, Cabrera-Pivaral CE. Effect of oral administration of ascorbic acid on insulin sensitivity and lipid profile in obese individuals. Rev Invest Clin 2001; 53: 50510.
  • 33
    Hamilton IM, Gilmore WS, Benzie IF, Mulholland CW, Strain JJ. Interactions between vitamins C and E in human subjects. Br J Nutr 2000; 84: 2617.
  • 34
    Rokitzki L, Logemann E, Sagredos AN, Murphy M, Wetzel-Roth W, Keul J. Lipid peroxidation and antioxidative vitamins under extreme endurance stress. Acta Physiol Scand 1994; 151: 14958.
  • 35
    Maxwell SR, Jakeman P, Thomason H, Leguen C, Thorpe GH. Changes in plasma antioxidant status during eccentric exercise and the effect of vitamin supplementation. Free Radic Res Commun 1993; 19: 191202.
  • 36
    Kyllastinen MJ, Elfving SM, Gref CG, Aro A. Dietary vitamin C supplementation and common laboratory values in the elderly. Arch Gerontol Geriatr 1990; 10: 297301.
  • 37
    Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345: 158392.
  • 38
    Menne IV, Grey PC, Kotze JP, Sommers DK, Brown JM, Spies JH. Ascorbic acid and blood lipid and uric acid levels of students. S Afr Med J 1975; 49: 22258.
  • 39
    Machefer G, Groussard C, Vincent S, Zouhal H, Faure H, Cillard J, et al. Multivitamin-mineral supplementation prevents lipid peroxidation during “the Marathon des Sables”. J Am Coll Nutr 2007; 26: 11120.
  • 40
    Mastaloudis A, Morrow JD, Hopkins DW, Devaraj S, Traber MG. Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners. Free Radic Biol Med 2004; 36: 132941.
  • 41
    Hillert L, Kolmodin-Hedman B, Eneroth P, Arnetz BB. The effect of supplementary antioxidant therapy in patients who report hypersensitivity to electricity: a randomized controlled trial. MedGenMed 2001; 3: 11.
  • 42
    Midgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996; 275: 15907.
  • 43
    Streppel MT, Arends LR, van 't Veer P, Grobbee DE, Geleijnse JM. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med 2005; 165: 1506.
  • 44
    Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith D, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publishing Group; 2001. p. 289.
  • 45
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 153958.
  • 46
    Beser E. The effects of short-term vitamin C on plasma BUN, uric acid, cholesterol and triglyceride levels. Acta Med Hung 1991; 48: 738.
  • 47
    Hodges RE, Hood J, Canham JE, Sauberlich HE, Baker EM. Clinical manifestations of ascorbic acid deficiency in man. Am J Clin Nutr 1971; 24: 43243.
  • 48
    Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids: a report of the Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients and Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes Food Nutrition Board. Washington, DC: National Academies Press; 2000.
  • 49
    Hathcock JN, Azzi A, Blumberg J, Bray T, Dickinson A, Frei B, et al. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr 2005; 81: 73645.
  • 50
    Urivetzky M, Kessaris D, Smith AD. Ascorbic acid overdosing: a risk factor for calcium oxalate nephrolithiasis. J Urol 1992; 147: 12158.
  • 51
    Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002; 417: 44752.
  • 52
    Thangaraju M, Ananth S, Martin PM, Roon P, Smith SB, Sterneck E, et al. c/ebpdelta Null mouse as a model for the double knock-out of slc5a8 and slc5a12 in kidney. J Biol Chem 2006; 281: 2676973.
  • 53
    Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 2008; 372: 195361.
  • 54
    Tian N, Thrasher KD, Gundy PD, Hughson MD, Manning RD Jr. Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension. Hypertension 2005; 45: 9349.
  • 55
    Schaufele TG, Schlaich MP, Delles C, Klingbeil AU, Fleischmann EH, Schmieder RE. Impaired basal NO activity in patients with glomerular disease and the influence of oxidative stress. Kidney Int 2006; 70: 117781.
  • 56
    Chade AR, Rodriguez-Porcel M, Herrmann J, Krier JD, Zhu X, Lerman A, et al. Beneficial effects of antioxidant vitamins on the stenotic kidney. Hypertension 2003; 42: 60512.
  • 57
    Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 1989; 86: 637781.
  • 58
    Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21: 155973.
  • 59
    Gochman N, Schmitz JM. Automated determination of uric acid, with use of a uricase-peroxidase system. Clin Chem 1971; 17: 11549.
  • 60
    Young DS, Thomas DW, Friedman RB, Pestaner LC. Effects of drugs on clinical laboratory tests. Clin Chem 1972; 18: 1041303.
  • 61
    Siest G, Appel W, Blijenberg GB, Capolaghi B, Galteau MM, Heusghem C, et al. Drug interference in clinical chemistry: studies on ascorbic acid. J Clin Chem Clin Biochem 1978; 16: 10310.
  • 62
    Mitch WE, Johnson MW, Kirshenbaum JM, Lopez RE. Effect of large oral doses of ascorbic acid on uric acid excretion by normal subjects. Clin Pharmacol Ther 1981; 29: 31821.
  • 63
    Badrick TC, Campbell B. Effects of intravenous infusion of ascorbate on common clinical chemistry tests [letter]. Clin Chem 1992; 38: 2160.
  • 64
    Bouvier D, Sapin V, Bonnard-Gougeon M, Marceau G. Retinol potentiates the inhibitory effect of ascorbic acid on uric acid assay. Clin Chem Lab Med 2010; 48: 6935.
  • 65
    Christian DG. Drug interference with laboratory blood chemistry determinations. Am J Clin Pathol 1970; 54: 11842.
  • 66
    Singh HP, Hebert MA, Gault MH. Effect of some drugs on clinical laboratory values as determined by the technicon SMA 12-60. Clin Chem 1972; 18: 13744.
  • 67
    Martinello F, da Silva EL. Ascorbic acid interference in the measurement of serum biochemical parameters: in vivo and in vitro studies. Clin Biochem 2006; 39: 396403.
  • 68
    Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969; 22: 15861.
  • 69
    Martinello F, Luiz da Silva E. Mechanism of ascorbic acid interference in biochemical tests that use peroxide and peroxidase to generate chromophore. Clin Chim Acta 2006; 373: 10816.
  • 70
    Fossati P, Prencipe L, Berti G. Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 1980; 26: 22731.
  • 71
    Zoppi F, Fenili D. Drug interferences in reactions for detecting hydrogen peroxide by means of peroxidase [letter]. Clin Chem 1980; 26: 122930.
  • 72
    Yu TF, Gutman AB. Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest 1959; 38: 1298315.
  • 73
    Caspi D, Lubart E, Graff E, Habot B, Yaron M, Segal R. The effect of mini-dose aspirin on renal function and uric acid handling in elderly patients. Arthritis Rheum 2000; 43: 1038.
  • 74
    Louthrenoo W, Kasitanon N, Wichainun R, Sukitawut W. Effect of minidose aspirin on renal function and renal uric acid handling in healthy young adults. J Clin Rheumatol 2002; 8: 299304.
  • 75
    Segal R, Lubart E, Leibovitz A, Iaina A, Caspi D. Renal effects of low dose aspirin in elderly patients. Isr Med Assoc J 2006; 8: 67982.
  • 76
    Beeley L, Kendall MJ. Effect of aspirin on renal clearance of 125I-diatrizoate. Br Med J 1971; 1: 7078.
  • 77
    Kimberly RP, Plotz PH. Aspirin-induced depression of renal function. N Engl J Med 1977; 296: 41824.
  • 78
    Haralambie G, Senser L. Metabolic changes in man during long-distance swimming. Eur J Appl Physiol Occup Physiol 1980; 43: 11525.
  • 79
    Sutton JR, Toews CJ, Ward GR, Fox IH. Purine metabolism during strenuous muscular exercise in man. Metabolism 1980; 29: 25460.
  • 80
    Francis K, Hamrick ME. Exercise and uric acid: implication in cardiovascular disease. J Orthop Sports Phys Ther 1984; 6: 349.
  • 81
    Janssen GM, Degenaar CP, Menheere PP, Habets HM, Geurten P. Plasma urea, creatinine, uric acid, albumin, and total protein concentrations before and after 15-, 25-, and 42-km contests. Int J Sports Med 1989; 10 Suppl: S1328.
  • 82
    Gonzalez D, Marquina R, Rondon N, Rodriguez-Malaver AJ, Reyes R. Effects of aerobic exercise on uric acid, total antioxidant activity, oxidative stress, and nitric oxide in human saliva. Res Sports Med 2008; 16: 12837.
  • 83
    Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 181121.
  • 84
    Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 2008; 300: 212333.
  • 85
    Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, et al. A randomized factorial trial of vitamins C and E and β carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med 2007; 167: 16108.
  • 86
    Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007; 297: 84257.